← All Sponsors
SPONSOR

Nordsjaellands Hospital

Total Trials
2
Recruiting
2
Phases
Phase 4

Nordsjaellands Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Tracheal Intubation, Video Laryngoscopy, Remifentanil, Rocuronium.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Nordsjaellands Hospital

How many clinical trials has Nordsjaellands Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Nordsjaellands Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Tracheal Intubation, Video Laryngoscopy, Remifentanil. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nordsjaellands Hospital research focus on?
Nordsjaellands Hospital clinical trials span Tracheal Intubation, Video Laryngoscopy, Remifentanil, Rocuronium, Fluid Accumulation, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nordsjaellands Hospital clinical trial?
To participate in a Nordsjaellands Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nordsjaellands Hospital trials with current recruitment status updated daily.

Clinical Trials by Nordsjaellands Hospital

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology